IRF3 and cancer: Our results revealed that ABCC10 suppresses the STING-TBK1-IRF3 pathway, thereby facilitating cancer cell resistance to RT both in vitro and in vivo, consistent with previous publications regarding STING activation and RT efficiency [11].